|
Volumn 33, Issue 7-8, 2001, Pages 3439-3441
|
A single-centre experience with cyclosporine microemulsion versus tacrolimus in 100 randomized liver transplant recipients: Midterm efficacy and safety
a,b a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CHOLESTEROL;
CREATININE;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
INSULIN;
METHYLPREDNISOLONE;
PREDNISONE;
STEROID;
TACROLIMUS;
TRIACYLGLYCEROL;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CHOLESTASIS;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DIABETES MELLITUS;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEMALE;
FOLLOW UP;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTRIGLYCERIDEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER CIRRHOSIS;
LIVER FAILURE;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
METABOLIC DISORDER;
MICROEMULSION;
NEPHROTOXICITY;
NEUROTOXICITY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL RATE;
SURVIVAL TIME;
TREATMENT INDICATION;
CYCLOSPORINE;
EMULSIONS;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
SAFETY;
SURVIVAL RATE;
TACROLIMUS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 0035671863
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02482-4 Document Type: Article |
Times cited : (13)
|
References (14)
|